Holst, Jens J.

Efficacy and safety of glimepiride with or without linagliptin treatment in patients with HNF1A diabetes (maturity-onset diabetes of the young type 3): a randomized, double-blinded, placebo-controlled, crossover trial (GLIMLINA)

Christensen, A. S., Hædersdal, S., Støy, J., Storgaard, H., Kampmann, U., Forman, J. L., Seghieri, M., Holst, J. J., Hansen, T., Knop, F. K., et al. (2020) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 48

Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity

Winther, J. B., & Holst, J. J. (2024) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 47

Delayed β-cell response and glucose intolerance in young women with Turner syndrome

Hjerrild, B. E., Holst, J. J., Juhl, C. B., Christiansen, J. S., Schmitz, O., & Gravholt, C. H. (2011) · BMC Endocrine Disorders

Pancreatic function and diabetesGenetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities

Cited by 45

Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: a randomized controlled trial in patients with type 2 diabetes

Nauck, M. A., Kahle, M., Baranov, O., Deacon, C. F., & Holst, J. J. (2017) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 44

Therapies for inter-relating diabetes and obesity – GLP-1 and obesity

Iepsen, E. W., Torekov, S. S., & Holst, J. J. (2014) · Expert Opinion on Pharmacotherapy

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 43

The promise of glucagon-like peptide 1 receptor agonists (GLP-1RA) for the treatment of obesity: a look at phase 2 and 3 pipelines

Madsbad, S., & Holst, J. J. (2025) · Expert Opinion on Investigational Drugs

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 43

GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report

Iepsen, E. W., Have, C. T., Veedfald, S., Madsbad, S., Holst, J. J., Grarup, N., Pedersen, O., Brandslund, I., Holm, J.-C., Hansen, T., et al. (2020) · Cell Reports Medicine

Diabetes Treatment and ManagementRegulation of Appetite and Obesity

Cited by 43

Exploratory analysis of eating-and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment

Jensen, S. B. K., Janus, C., Lundgren, J. R., Juhl, C. R., Sandsdal, R. M., Olsen, L. M., Andresen, A., Borg, S. A., Jacobsen, I. C., Finlayson, G., et al. (2022) · Nature Communications

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 42

Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes

Ranjan, A., Schmidt, S., Madsbad, S., Holst, J. J., & Nørgaard, K. (2016) · Diabetes, Obesity and Metabolism

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 39

GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism

Boer, G. A., Keenan, S. N., Miotto, P. M., Holst, J. J., & Watt, M. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism

Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases

Cited by 38

The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes

Dalsgaard, N. B., Gasbjerg, L. S., Hansen, L. S., Hansen, N. L., Stensen, S., Hartmann, B., Rehfeld, J. F., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2021) · European Journal of Endocrinology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 37

GIP-induced vasodilation in human adipose tissue involves capillary recruitment

Asmar, M., Asmar, A., Simonsen, L., Dela, F., Holst, J. J., & Bülow, J. (2019) · Endocrine Connections

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 37

Searching for the physiological role of glucose‐dependent insulinotropic polypeptide

Holst, J. J., Windeløv, J. A., Boer, G. A., Pedersen, J., Svendsen, B., Christensen, M., Torekov, S., Asmar, M., Hartmann, B., & Nissen, A. (2016) · Journal of Diabetes Investigation

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 36

Pancreatic Glucagon Response to an Ordinary Meal

Dencker, H., Hedner, P., Holst, J., & Tranberg, K.-G. (1975) · Scandinavian Journal of Gastroenterology

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 35

Bile acid mediated effects on gut integrity and performance of early weaned piglets

de Diego-Cabero, N., Mereu, A., Menoyo, D., Holst, J. J., & Ipharraguerre, I. R. (2015) · BMC Veterinary Research

Animal Nutrition and PhysiologyVeterinary medicine and infectious diseases

Cited by 35

Erratum: Effect of GLP ‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: A randomized, placebo‐controlled trial

Ebdrup, B. H., Broberg, B. V., Ishøy, P. L., Bak, N., Andersen, U. B., Jørgensen, N. R., Holst, J. J., Knop, F. K., & Glenthøj, B. Y. (2018) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentSchizophrenia research and treatment

Cited by 35

Sex Steroids Affect Triglyceride Handling, Glucose-Dependent Insulinotropic Polypeptide, and Insulin Sensitivity

Lapauw, B., Ouwens, M., ′t Hart, L. M., Wuyts, B., Holst, J. J., T'Sjoen, G., Kaufman, J.-M., & Ruige, J. B. (2010) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsHormonal and reproductive studies

Cited by 32

Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double‐blind, placebo‐controlled trial

Dejgaard, T. F., Frandsen, C. S., Kielgast, U., Størling, J., Overgaard, A. J., Svane, M. S., Olsen, M. H., Thorsteinsson, B., Andersen, H. U., Krarup, T., et al. (2024) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 29

Instrumentalization of Eating Improves Weight Loss Maintenance in Obesity

Christensen, B. J., Iepsen, E. W., Lundgren, J., Holm, L., Madsbad, S., Holst, J. J., & Torekov, S. S. (2017) · Obesity Facts

Eating Disorders and BehaviorsNutrition, Health and Food Behavior

Cited by 28

Glucagonostatic potency of GLP-1 in patients with type 2 diabetes, patients with type 1 diabetes, and healthy control subjects

Bagger, J. I., Grøndahl, M. F. G., Lund, A., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2021) · Diabetes

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 27

Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System: The 2021 Banting Medal for Scientific Achievement Award Lecture

Holst, J. J. (2021) · Diabetes

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 23

Comparisons of leptin, incretins and body composition in obese and lean patients with hypopituitarism and healthy individuals

Mersebach, H., Svendsen, O. L., Holst, J. J., Astrup, A., & Feldt‐Rasmussen, U. (2003) · Clinical Endocrinology

Regulation of Appetite and ObesityGrowth Hormone and Insulin-like Growth Factors

Cited by 22

On the Effects of Glucagon-Like Peptide-1 on Blood Glucose Regulation in Normal and Diabetic Subjects

HOLST, J. J., TOFT-NIELSEN, M.-B., ØRSKOV, C., NAUCK, M., & WILLMS, B. (2006) · Annals of the New York Academy of Sciences

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 21

Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet

Jensen, S. B. K., Lundgren, J. R., Janus, C., Juhl, C. R., Olsen, L. M., Rosenkilde, M., Holst, J. J., Stallknecht, B. M., Madsbad, S., & Torekov, S. S. (2019) · BMJ Open

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 20